Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa: Single-blind Randomized Clinical Trial of Safety and Efficacy [Original Articles]
Conclusions—
Administration of epoetin alfa to older adult patients with heart failure and a preserved ejection fraction compared with placebo did not change left ventricular end-diastolic volume and left ventricular mass nor did it improve submaximal exercise capacity or quality of life.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00286182.
Source: Circulation: Heart Failure - Category: Cardiology Authors: Maurer, M. S., Teruya, S., Chakraborty, B., Helmke, S., Mancini, D. Tags: Other heart failure, Remodeling, Other Treatment Original Articles Source Type: research
More News: Anemia | Cardiology | Cardiomyopathy | Clinical Trials | Epogen | Eyes | Heart | Heart Failure | Procrit | Sports Medicine | Stroke | Study | Women